Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001213900-25-047471
Filing Date
2025-05-27
Accepted
2025-05-23 18:20:42
Documents
120

Document Format Files

Seq Description Document Type Size
1 POST-EFFECTIVE AMENDMENT NO. 4 TO FORM S-1 ea0243397-posam4_abvcbio.htm   iXBRL POS AM 3904979
2 CONSENT OF SIMON & EDWARD, LLP ea024339701ex23-2_abvcbio.htm EX-23.2 2432
3 GRAPHIC image_001.jpg GRAPHIC 4376
4 GRAPHIC image_002.jpg GRAPHIC 62898
5 GRAPHIC image_003.jpg GRAPHIC 21974
6 GRAPHIC fin_001.jpg GRAPHIC 21048
7 GRAPHIC ex23-1_001.jpg GRAPHIC 70614
8 GRAPHIC ex23-1_002.jpg GRAPHIC 2954
  Complete submission text file 0001213900-25-047471.txt   18265919

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE abvc-20250331.xsd EX-101.SCH 118250
10 XBRL CALCULATION FILE abvc-20250331_cal.xml EX-101.CAL 74858
11 XBRL DEFINITION FILE abvc-20250331_def.xml EX-101.DEF 654874
12 XBRL LABEL FILE abvc-20250331_lab.xml EX-101.LAB 949629
13 XBRL PRESENTATION FILE abvc-20250331_pre.xml EX-101.PRE 696960
124 EXTRACTED XBRL INSTANCE DOCUMENT ea0243397-posam4_abvcbio_htm.xml XML 3105630
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
ABVC BIOPHARMA, INC. (Filer) CIK: 0001173313 (see all company filings)

EIN.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-255112 | Film No.: 25983741
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)